Side effects of drugs used in IC

Not Applicable

Completed

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J100- Influenza due to other identifiedinfluenza virus with pneumonia

• Registration Number: CTRI/2020/11/028800
• Lead Sponsor: Government Institute of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-03-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 396

Inclusion Criteria

All Patients diagnosed with COVID 19 disease admitted in the COVID ICU will be included in the study.

Exclusion Criteria

NI

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adverse Drug reactionTimepoint: baseline, day 1, 2 , 3, 4, 5, 6, 7,8, 9, 10, 11,12, 13, 14,

Secondary Outcome Measures

Name	Time	Method
1.Demographic parameters (age and gender). <br/ ><br>2.Number of medications. <br/ ><br>3.Associated co-morbid conditions. <br/ ><br>4.Length of ICU stay. <br/ ><br>Timepoint: at admission and discharge